Who are 1200 Pharma's investors?

1200 Pharma's investors include Kairos Venture Investments, Llc, OCV Partners.

How much funding has 1200 Pharma raised?

1200 Pharma has disclosed $14.1M raised across 3 rounds.

Where is 1200 Pharma headquartered?

1200 Pharma is headquartered in Culver City, US.

1200 Pharma

Culver City, US · Delaware LLC · 2 known investors

Develops novel oncology therapeutics using breakthrough medicinal chemistry technology and biomarker-driven assays to accelerate drug discovery and clinical approval timelines.

Founders & leadership

Brian StoltzNamed on SEC filing

Mark AttanasioNamed on SEC filing

David ChangNamed on SEC filing

David LicataNamed on SEC filing

Dennis SlamonNamed on SEC filing

Investors · 2

Kairos Venture Investments, LlcBeverly Hills · $150K – $20M

OCV PartnersLos Angeles

Reported raises · per SEC filings

Form D private placements

$14.1M disclosed across 3 rounds · 2017–2024

▶$2.3MraisedApr 2024 · 30 investors · Other Technology

Rule 506(b)

Officers, directors & promoters on the filing

Brian StoltzDirector
Mark AttanasioDirector
David ChangDirector
David LicataDirector
Dennis SlamonDirector

Amount sold: $2.3M
First sale: Apr 2024
Incorporated: Limited Liability Company, Delaware
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$5.5MraisedDec 2019 · 5 investors · Other Technology

Rule 506(b)

Officers, directors & promoters on the filing

DAVID LICATAExecutive Officer
LEE SAILORExecutive Officer

Offering amount: $5.5M
Amount sold: $5.5M
Minimum investment: $10K
First sale: Nov 2019
Incorporated: Limited Liability Company, Delaware, 2017
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$6.2MraisedNov 2017 · 2 investors · Other Technology

Rule 506(b)

Officers, directors & promoters on the filing

Lee SailorExecutive Officer
David LicataExecutive Officer

Offering amount: $12.5M
Amount sold: $6.2M
Minimum investment: $10K
First sale: Nov 2017
Incorporated: Limited Liability Company, Delaware, 2017
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

1200 Pharma has filed a notice of an exempt offering of securities to raise $2,325,500.00 in New Equity Investment. - intelligence360intelligence360.news · May 2024

Frequently asked questions

What does 1200 Pharma do?: Develops novel oncology therapeutics using breakthrough medicinal chemistry technology and biomarker-driven assays to accelerate drug discovery and clinical approval timelines.
Who are 1200 Pharma's investors?: 1200 Pharma's investors include Kairos Venture Investments, Llc, OCV Partners.
How much funding has 1200 Pharma raised?: 1200 Pharma has disclosed $14.1M raised across 3 rounds.
Where is 1200 Pharma headquartered?: 1200 Pharma is headquartered in Culver City, US.